IMCR
Immunocore Holdings Ltd
30.30$
-1.8%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 89.1% | 83.7% | 87.2% | 73.4% | 87.4% | 66.9% | 77.6% | 87.1% | 90.0% | 88.6% | 92.1% | 93.4% | |
| 83.5% | 80.4% | 61.3% | 42.4% | 63.5% | 39.8% | 89.6% | 78.8% | 76.4% | 74.1% | 45.1% | 43.8% | |
| 83.5% | 80.4% | 80.6% | 59.9% | 63.5% | 39.8% | 89.6% | 78.8% | 76.4% | 74.1% | 81.3% | 81.0% | |
| 0.3% | 0.1% | 0.2% | 0.0% | 2.2% | 27.0% | 1.0% | 8.2% | 10.8% | 10.3% | 8.2% | 6.9% | |
| – | – | – | – | -3.9% | -1.8% | -3.3% | -1.9% | 0.1% | 0.8% | 0.5% | 0.6% | |
| – | – | 5.0% | 12.1% | 10.7% | 22.3% | 18.7% | 7.7% | 6.0% | – | – | – | |
| – | – | – | – | – | – | – | – | 0.1% | – | – | – | |
| 0.3% | 0.1% | 0.2% | 0.4% | 0.2% | – | – | 6.1% | 0.0% | – | – | – | |
| 103.5% | 21.6% | 20.1% | 30.5% | 71.1% | 92.0% | 71.9% | 43.2% | 35.7% | 38.2% | 64.3% | 64.3% | |
| 30.6% | 8.3% | 10.0% | 15.2% | 25.3% | 45.5% | 27.9% | 20.3% | 19.1% | 23.3% | 21.0% | 23.1% | |
| – | – | – | – | – | 11.4% | 6.4% | 0.4% | 0.4% | 0.2% | 0.2% | 0.2% | |
| 1.4% | 1.3% | 1.4% | 4.1% | 3.3% | 8.5% | 4.0% | 2.5% | 2.7% | 3.0% | 2.5% | 2.3% | |
| – | – | – | – | 9.6% | – | 18.6% | 9.1% | 7.5% | 8.0% | 38.7% | 36.8% | |
| -3.5% | 78.4% | 79.9% | 69.5% | 28.9% | 8.0% | 28.1% | 56.8% | 64.3% | 61.8% | 35.7% | 35.7% | |
| -45.6% | -4.0% | -27.9% | -56.3% | -89.5% | -150.3% | -177.4% | -159.5% | -130.9% | -124.7% | -78.8% | -77.9% | |
| 3.6% | – | 1.1% | 1.2% | 13.9% | 11.1% | 16.1% | 10.8% | 8.7% | 8.2% | 5.0% | 4.7% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.